Portfolio
Matisse Pharmaceuticals meets primary objectives in study with M6229 in critically ill sepsis patients
30.01.2024
30.01.2024
24.01.2024
23.01.2024
10.01.2024
04.01.2024
04.01.2024
07.12.2023
09.10.2023